Morvarid Mohseni

4.2k total citations · 1 hit paper
24 papers, 2.2k citations indexed

About

Morvarid Mohseni is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Morvarid Mohseni has authored 24 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 7 papers in Cell Biology and 6 papers in Immunology. Recurrent topics in Morvarid Mohseni's work include Protein Tyrosine Phosphatases (9 papers), Hippo pathway signaling and YAP/TAZ (5 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Morvarid Mohseni is often cited by papers focused on Protein Tyrosine Phosphatases (9 papers), Hippo pathway signaling and YAP/TAZ (5 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Morvarid Mohseni collaborates with scholars based in United States, Switzerland and Iran. Morvarid Mohseni's co-authors include Karin Schlegelmilch, Thijn R. Brummelkamp, Oktay Kirak, Valeri Vasioukhin, Jan Pruszak, Bridget Kreger, Dawang Zhou, Joseph Avruch, Fernando D. Camargo and Richard I. Gregory and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Morvarid Mohseni

24 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Yap1 Acts Downstream of α-Catenin to Control Epidermal Proliferation

2011 836 citations Karin Schlegelmilch, Morvarid Mohseni et al. Cell profile →

Peers

Morvarid Mohseni

ONCOL

IMMUN

Kimberly C. Lin United States

John M. Lamar United States

Jie Leng United States

Kathy Knezevic Australia

Jonathan Grim United States

Ana Cerezo Spain

Takako Ooshio Japan

Harold I. Saavedra United States

W G King United States

Abdullah Mahmood Ali United States

Kimberly C. Lin United States

Morvarid Mohseni

1.2k ×0.9

1.0k ×0.8

188 ×0.6

ONCOL

143 ×0.5

91 ×0.4

IMMUN

Citations per year, relative to Morvarid Mohseni Morvarid Mohseni (= 1×) peers Kimberly C. Lin

Countries citing papers authored by Morvarid Mohseni

Since Specialization

Citations

This map shows the geographic impact of Morvarid Mohseni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morvarid Mohseni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morvarid Mohseni more than expected).

Fields of papers citing papers by Morvarid Mohseni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morvarid Mohseni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morvarid Mohseni. The network helps show where Morvarid Mohseni may publish in the future.

Co-authorship network of co-authors of Morvarid Mohseni

This figure shows the co-authorship network connecting the top 25 collaborators of Morvarid Mohseni. A scholar is included among the top collaborators of Morvarid Mohseni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morvarid Mohseni. Morvarid Mohseni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yerrum, Smitha, Ye Zhang, Mark A. Murakami, et al.. (2025). High-throughput single-cell density measurements enable dynamic profiling of immune cell and drug response from patient samples. Nature Biomedical Engineering. 9(11). 1972–1981. 1 indexed citations

Mohseni, Morvarid, et al.. (2024). MicroRNAs regulating autophagy: opportunities in treating neurodegenerative diseases. Frontiers in Neuroscience. 18. 1397106–1397106. 3 indexed citations

Mohseni, Morvarid, et al.. (2024). MicroRNA frontiers: Illuminating early detection paths in multiple sclerosis. Multiple Sclerosis and Related Disorders. 95. 106237–106237. 2 indexed citations

Coissieux, Marie‐May, Vincent Romanet, Atul Sethi, et al.. (2023). PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer. Journal of Mammary Gland Biology and Neoplasia. 28(1). 13–13. 7 indexed citations

Vemulapalli, Vidyasiri, Lily A. Chylek, Alison R. Erickson, et al.. (2021). Time-resolved phosphoproteomics reveals scaffolding and catalysis-responsive patterns of SHP2-dependent signaling. eLife. 10. 16 indexed citations

Lu, Hengyu, Chen Liu, Roberto Velazquez, et al.. (2019). SHP2 Inhibition Overcomes RTK-Mediated Pathway Reactivation in KRAS-Mutant Tumors Treated with MEK Inhibitors. Molecular Cancer Therapeutics. 18(7). 1323–1334. 58 indexed citations

Pandey, Ruchi, Changlin Wan, George E. Sandusky, et al.. (2019). SHP2 inhibition reduces leukemogenesis in models of combined genetic and epigenetic mutations. Journal of Clinical Investigation. 129(12). 5468–5473. 29 indexed citations

Lu, Hengyu, Chen Liu, Roberto Velazquez, et al.. (2019). Abstract 954: SHP2 inhibition overcomes RTK-mediated pathway reactivation in KRAS mutant tumors treated with MEK inhibitors. 954–954. 1 indexed citations

LaRochelle, Jonathan R., Michelle Fodor, Vidyasiri Vemulapalli, et al.. (2018). Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition. Nature Communications. 9(1). 4508–4508. 105 indexed citations

10.

Cai, Zhigang, Jonathan J. Kotzin, Baskar Ramdas, et al.. (2018). Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis. Cell stem cell. 23(6). 833–849.e5. 251 indexed citations

11.

Cai, Zhigang, Jonathan J. Kotzin, Baskar Ramdas, et al.. (2018). Downregulation of Morrbid in Tet2-Deficient Preleukemic Cells Overcomes Resistance to Inflammatory Stress and Mitigates Clonal Hematopoiesis. Blood. 132(Supplement 1). 1288–1288. 1 indexed citations

12.

Karpov, Alexei S., Tinya J. Abrams, Joseph A. D’Alessio, et al.. (2018). Nicotinamide Phosphoribosyltransferase Inhibitor as a Novel Payload for Antibody–Drug Conjugates. ACS Medicinal Chemistry Letters. 9(8). 838–842. 29 indexed citations

13.

LaRochelle, Jonathan R., Michelle Fodor, Jana M. Ellegast, et al.. (2017). Identification of an allosteric benzothiazolopyrimidone inhibitor of the oncogenic protein tyrosine phosphatase SHP2. Bioorganic & Medicinal Chemistry. 25(24). 6479–6485. 33 indexed citations

14.

Ladd, Brendon, Anne Marie Mazzola, Teeru Bihani, et al.. (2016). Effective combination therapies in preclinical endocrine resistant breast cancer models harboring ER mutations. Oncotarget. 7(34). 54120–54136. 22 indexed citations

15.

Lau, Allison N., Stephen J. Curtis, Christine M. Fillmore, et al.. (2014). Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis. The EMBO Journal. 33(5). 468–481. 168 indexed citations

16.

Mori, Masaki, Robinson Triboulet, Morvarid Mohseni, et al.. (2014). Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer. Cell. 156(5). 893–906. 283 indexed citations

17.

Mohseni, Morvarid, Jianlong Sun, Allison N. Lau, et al.. (2013). A genetic screen identifies an LKB1–MARK signalling axis controlling the Hippo–YAP pathway. Nature Cell Biology. 16(1). 108–117. 232 indexed citations

18.

Schlegelmilch, Karin, Morvarid Mohseni, Oktay Kirak, et al.. (2011). Yap1 Acts Downstream of α-Catenin to Control Epidermal Proliferation. Cell. 144(5). 782–795. 836 indexed citations breakdown →

19.

Mohseni, Morvarid & Athar H. Chishti. (2009). Regulatory models of RhoA suppression by dematin, a cytoskeletal adaptor protein. Cell Adhesion & Migration. 3(2). 191–194. 7 indexed citations

20.

Khan, Anwar, Toshihiko Hanada, Morvarid Mohseni, et al.. (2008). Dematin and Adducin Provide a Novel Link between the Spectrin Cytoskeleton and Human Erythrocyte Membrane by Directly Interacting with Glucose Transporter-1. Journal of Biological Chemistry. 283(21). 14600–14609. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact